FAIR

Main information

  • Trade name:
  • FAIR - GEL
  • Pharmaceutical form:
  • GEL
  • Composition:
  • -
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FAIR - GEL
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

11-9-2018

Assessment of occupational and dietary exposure to pesticide residues

Assessment of occupational and dietary exposure to pesticide residues

Published on: Mon, 27 Aug 2018 00:00:00 +0200 Plant protection products (PPPs) are pesticides containing at least one active substance that drives specific actions against pests (diseases). PPPs are regulated in the EU and cannot be placed on the market or used without prior authorisation. EFSA assesses the possible risks of the use of active substances to humans and environment. Member States decide whether or not to approve their use at EU level. Furthermore, Member States decide at national level on ...

Europe - EFSA - European Food Safety Authority Publications

2-8-2018

Fairy capsules

Fairy capsules

Fairy capsules pose a serious risk to your health and should not be taken.

Therapeutic Goods Administration - Australia

27-7-2018

Agathe Denéchère appointed Deputy Director General for General Affairs at ANSES

Agathe Denéchère appointed Deputy Director General for General Affairs at ANSES

France - Agence Nationale du Médicament Vétérinaire

10-10-2017

The Danish Medicines Agency contributes to review of Chinese medicines act

The Danish Medicines Agency contributes to review of Chinese medicines act

On Monday 9 October, a Chinese delegation headed by Xu Jinghe visited the Danish Medicines Agency. Xu Jinghe is Director General of the CFDA's Department of Legal Affairs and one of the main architects of the renewal of the Chinese medicines legislation.

Danish Medicines Agency

2-5-2018

TGA presentation: Medicines Australia Regulatory Affairs Working Group, 18 April 2018

TGA presentation: Medicines Australia Regulatory Affairs Working Group, 18 April 2018

Update on TGA activities from the Scientific Evaluation Branch

Therapeutic Goods Administration - Australia